Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-005186-31Phase 3Terminated
A Phase 3 trial of autologous adipose-derived mesenchymal stromal cells in breast cancer, BRCA2 gene mutation, breast reconstruction, sponsored by Department of Plastic Surgery, Breast and Burns Treatment. Started Jun 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-005186-31.